Matches in SemOpenAlex for { <https://semopenalex.org/work/W4200267998> ?p ?o ?g. }
Showing items 1 to 74 of
74
with 100 items per page.
- W4200267998 endingPage "S150" @default.
- W4200267998 startingPage "S150" @default.
- W4200267998 abstract "Abstract Background Fluoroquinolone (FQ) antibiotics are frequently used in hospitalized patients to treat a wide range of infections but are often misused and implicated in antibiotic-associated adverse events. The purpose of this study is to evaluate the impact of Infectious Disease fellow (IDF)-driven antimicrobial stewardship program (ASP) interventions on inpatient FQ use. Methods This is a retrospective study of all admitted patients who received a FQ for greater than 48 hours from 01/01/2019 -12/31/2020 in an urban academic center. “Phase 1” (pre-intervention phase) covered 01/1/2019- 03/31/2019. “Phase 2” (intervention phase) covered 03/03/2020- 12/23/2020. In “Phase 2”, our ASP reviewed FQ use 2-3 days per week and an IDF provided feedback interventions that averaged 30-60 minutes of IDF time spent per day. We categorized FQ use as either: “appropriate”, “appropriate but not preferred”, or “inappropriate”, as determined by local clinical guidelines and ASP team opinion. We compared FQ use in both phases, indications for FQ use, and new Clostridioides difficile infections (CDI). Results A total of 386 patients are included (76 in “Phase 1”and 310 in “Phase 2”). Patient characteristics are similar (Table 1). Overall, 63 % of FQ use was empiric, and 50% FQ use was deemed “appropriate”, 28% “appropriate but not preferred”, and 22% “inappropriate”. In “Phase 2”, 126 interventions were conducted, with 86% of these accepted. Appropriate FQ use increased significantly in “Phase 2” vs. “Phase 1” (53.5% vs 35.5%, p = 0.008), with decrease in mean days of FQ use (4.38 days vs 5.87 days, p =.021). Table 2 shows “appropriate” FQ use by clinical indication. New CDIs occurred more in “Phase 1” vs. “Phase 2” (6.6% vs 0.6%, p=.001). Conclusion An IDF-driven ASP intervention has a positive impact on appropriate inpatient use of FQs in our hospital. This highlights a promising ASP model which not only improves appropriate use of FQ, but also offers an opportunity for IDF mentorship and use of available resources to promote ASPs. Disclosures Katie A. McCrink, PharmD, ViiV Healthcare (Employee)" @default.
- W4200267998 created "2021-12-31" @default.
- W4200267998 creator A5022946713 @default.
- W4200267998 creator A5024688470 @default.
- W4200267998 creator A5025242930 @default.
- W4200267998 creator A5026812738 @default.
- W4200267998 creator A5037996203 @default.
- W4200267998 creator A5069101029 @default.
- W4200267998 date "2021-11-01" @default.
- W4200267998 modified "2023-09-26" @default.
- W4200267998 title "63. Impact of Infectious Disease Fellow-Driven Antimicrobial Stewardship Interventions on Inpatient Fluoroquinolone Use" @default.
- W4200267998 doi "https://doi.org/10.1093/ofid/ofab466.265" @default.
- W4200267998 hasPublicationYear "2021" @default.
- W4200267998 type Work @default.
- W4200267998 citedByCount "0" @default.
- W4200267998 crossrefType "journal-article" @default.
- W4200267998 hasAuthorship W4200267998A5022946713 @default.
- W4200267998 hasAuthorship W4200267998A5024688470 @default.
- W4200267998 hasAuthorship W4200267998A5025242930 @default.
- W4200267998 hasAuthorship W4200267998A5026812738 @default.
- W4200267998 hasAuthorship W4200267998A5037996203 @default.
- W4200267998 hasAuthorship W4200267998A5069101029 @default.
- W4200267998 hasBestOaLocation W42002679981 @default.
- W4200267998 hasConcept C118552586 @default.
- W4200267998 hasConcept C126322002 @default.
- W4200267998 hasConcept C177713679 @default.
- W4200267998 hasConcept C187212893 @default.
- W4200267998 hasConcept C197934379 @default.
- W4200267998 hasConcept C27415008 @default.
- W4200267998 hasConcept C2776040555 @default.
- W4200267998 hasConcept C2779134260 @default.
- W4200267998 hasConcept C2911146124 @default.
- W4200267998 hasConcept C501593827 @default.
- W4200267998 hasConcept C524204448 @default.
- W4200267998 hasConcept C71924100 @default.
- W4200267998 hasConcept C86803240 @default.
- W4200267998 hasConcept C89423630 @default.
- W4200267998 hasConcept C94665300 @default.
- W4200267998 hasConceptScore W4200267998C118552586 @default.
- W4200267998 hasConceptScore W4200267998C126322002 @default.
- W4200267998 hasConceptScore W4200267998C177713679 @default.
- W4200267998 hasConceptScore W4200267998C187212893 @default.
- W4200267998 hasConceptScore W4200267998C197934379 @default.
- W4200267998 hasConceptScore W4200267998C27415008 @default.
- W4200267998 hasConceptScore W4200267998C2776040555 @default.
- W4200267998 hasConceptScore W4200267998C2779134260 @default.
- W4200267998 hasConceptScore W4200267998C2911146124 @default.
- W4200267998 hasConceptScore W4200267998C501593827 @default.
- W4200267998 hasConceptScore W4200267998C524204448 @default.
- W4200267998 hasConceptScore W4200267998C71924100 @default.
- W4200267998 hasConceptScore W4200267998C86803240 @default.
- W4200267998 hasConceptScore W4200267998C89423630 @default.
- W4200267998 hasConceptScore W4200267998C94665300 @default.
- W4200267998 hasIssue "Supplement_1" @default.
- W4200267998 hasLocation W42002679981 @default.
- W4200267998 hasLocation W42002679982 @default.
- W4200267998 hasOpenAccess W4200267998 @default.
- W4200267998 hasPrimaryLocation W42002679981 @default.
- W4200267998 hasRelatedWork W1979115029 @default.
- W4200267998 hasRelatedWork W2083420216 @default.
- W4200267998 hasRelatedWork W2581299351 @default.
- W4200267998 hasRelatedWork W2601084421 @default.
- W4200267998 hasRelatedWork W2889432870 @default.
- W4200267998 hasRelatedWork W2978040984 @default.
- W4200267998 hasRelatedWork W3200197546 @default.
- W4200267998 hasRelatedWork W4280637011 @default.
- W4200267998 hasRelatedWork W4285725851 @default.
- W4200267998 hasRelatedWork W1529956864 @default.
- W4200267998 hasVolume "8" @default.
- W4200267998 isParatext "false" @default.
- W4200267998 isRetracted "false" @default.
- W4200267998 workType "article" @default.